Adidas' Insider Signal Faces Its Sternest Test: The Margin Question

CEO Bjørn Gulden's personal share purchase signals confidence as analysts diverge on Adidas, with targets ranging from €173 to €230.

When Bjørn Gulden dipped into his own pocket to buy roughly €500,000 worth of Adidas shares just over a week ago, he placed a very personal bet on the company he runs. It is the kind of move that cuts through the noise of target-price cuts and analyst squabbling — a chief executive willing to put money behind his own conviction after the stock has fallen around a quarter from its 52-week high.

The timing was telling. Adidas had just absorbed a fresh round of bearish commentary from the sell side, and the share price was nursing losses that many in the market felt were out of proportion to the underlying numbers. Gulden's purchase, disclosed through mandatory filings, lands alongside a continuing buyback programme that saw the company repurchase roughly 2.55 million shares in the second tranche by 7 August. Insider buying plus corporate repurchases: the message from inside the building is consistent, even if the analyst community cannot agree on what the equity is worth.

That disagreement is unusually wide. UBS analyst Robert Krankowski cut his price target to €173 two weeks ago, holding a "Neutral" rating, and cited growing investor scepticism over valuation multiples amid uncertain European consumer demand. Goldman Sachs followed in the same window, trimming its target to €180, also at "Neutral". Both banks pointed to soft sector signals from rival On and cautious margin guidance across the sneaker segment. UBS had earlier downgraded the stock from "Buy" in early August, slashing its target from €219, and reaffirmed that stance mid-month.

On the other side of the fence sits JPMorgan's Wendy Liu, who maintains an "Overweight" rating with a €230 target. She argues that despite currency headwinds, Adidas offers one of the best risk-reward profiles in the entire sector. The gap between €173 and €230 — more than 30 percent — is a chasm that reflects how differently the market's smartest money reads the company's operational substance.

The fundamental case leans toward Liu, at least on the top line. Adidas reported second-quarter revenue of €6.74 billion in late July, a 13.29 percent increase that hardly resembles a consumer spending freeze. Earnings per share of €2.10 edged past the prior year's €2.03 — modest progress, not a breakout, but hardly a red flag either. Since that report roughly three weeks ago, the stock has shed about 3.3 percent; since the UBS downgrade, another 4.6 percent. For a company growing at double digits with an insider buying, that reaction looks exaggerated.

The bear case, however, is not without substance. UBS's central concern is gross margin pressure, and the bank sees this as the defining issue for coming quarters. The China problem adds another layer: Bloomberg has reported ongoing challenges in that market, including the rebranding of the Terrex line to "Shanchuanli" last month. Such structural adjustments consume time and resources with no guaranteed payoff. Add in elevated FIFA World Cup marketing costs flagged in the prior month's reporting, and the question becomes whether these are one-off expenses or the beginning of a structural squeeze on profitability.

The bull camp counters with breadth. Adidas has pried Penn State away from Nike, ending a 33-year partnership and signalling real gains in US college sports. The Hellstar collaboration, including the Megaride S2, targets high-margin streetwear demand. The new "Chaos vs Control" football boot collection — featuring the F50 and Predator with technologies like NANOSTRIKE+ and STRIKEFRAME — reinforces the core franchise. And the Pharrell Williams "Tan" VIRGINIA Adistar Jellyfish drops globally via the CONFIRMED app on 22 August. Product launches rarely move the share price on their own, but they puncture the narrative of a brand losing its innovative edge.

Jefferies and DZ Bank held firm at "Buy" in late July, and Morningstar upgraded to "Buy" in early August. The stock currently trades around €153.85, roughly 23 percent below its 52-week high of €200.90 from last October. Technical indicators echo the tension: the RSI sits at 35.2, approaching oversold territory, while the share price hovers just 2.5 percent below its 200-day moving average. Annualised volatility of 46 percent tells its own story about how nervously the market is handling this name. The 52-week low of €130.20 offers a buffer of about 18 percent — comfort, but not certainty.

The next real test comes on 29 October with third-quarter results. Until then, the stock remains a contest between a CEO's conviction, a functioning buyback, a busy product pipeline — and a margin trajectory that UBS believes will deteriorate. The 30 percent spread between the lowest and highest analyst targets suggests the market itself has yet to reach a verdict. For investors with the stomach for it, the operative story — double-digit revenue growth, insider buying, ongoing repurchases — may well be stronger than the recent round of target cuts implies. But the margin question will not go away, and it is the one variable that could decide which camp is right.